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Abstract
Studies on the mechanisms of decidualization and endometriosis are often hampered by lack of primary
endometrial cells. To facilitate in vitro studies, we established a human endometrial stromal cell line, KC02-44D,
immortalized with human telomerase reverse transcriptase. Upon exposure to ovarian stimuli, KC02-44D cells
showed similar cytoskeletal marker or gene expression and biochemical phenotype to primary endometrial stromal
cells. KC02-44D would be useful for studies of human endometrial function and its associated pathologies.
Background
Decidualization is the process of differentiation of the
endometrium, the mucosa lining the uterine lumen. In
endometrial decidualization, estrogen receptor (ER) and
progesterone receptor (PR) expressions strictly regulate
t h et i s s u er e s p o n s i v e n e s st o cognate ligands. Estrogen
can autoregulate ER expression, and PR is a classical
estrogen target [1-3]. In humans, decidualization occurs
independently of a blastocyst signal during the second
half of the menstrual cycle and is controlled as a proges-
terone- and 3’,5’-cyclic adenosine monophosphate
(cAMP)-dependent event. Its initiation requires elevated
intracellular cAMP levels and sustained activation of the
protein kinase A (PKA) pathway; progestin and cAMP
synergistically induce decidualization in primary cul-
tured human endometrial stromal cells (ESCs) [4].
Decidual cells exhibit morphological changes and abun-
dant secretion of decidualization enhancers such as pro-
lactin and insulin-like growth factor-binding protein-1
(IGFBP-1) [4].
Endometriosis is the growth of endometrial epithelial
and stromal cells at ectopic sites outside the uterine cav-
ity. Interleukin (IL)-1b, a proinflammatory cytokine, is
considered to play an important role in the pathogenesis
of endometriosis [5,6]. However, the relationship
between IL-1b and abnormal growth of endometrial
cells is not clearly understood.
For investigations on the mechanisms of decidualiza-
tion and endometriosis, cultured human ESCs are desir-
able tools; however, the applicability of these cells is
largely restricted by the long cell-culture time and diffi-
culty in maintaining the primary ESC phenotype. Several
attempts have been made to immortalize human ESCs
by oncogenic transformation [7] or prolongation of cell
division by introducing human telomerase reverse tran-
scriptase (hTERT) [8-11]. However, the synergistic effect
of progestin and cAMP on the decidualization capacity
and the induction of the PR by estradiol (E2) have not
been fully reproduced in these cell lines. In this study,
we established an hTERT-immortalized ESC line, KC02-
44D, to facilitate in vitro studies. KC02-44D cells
responded in a similar manner to primary human ESCs,
showing the synergistic induction of decidualization by
progestin and cAMP, and PR upregulation by E2.
Methods
Human tissue samples
Endometrial tissue was obtained from the uterus of a
45-year-old woman who had undergone total hysterect-
omy because of leiomyoma, after her written informed
consent and Keio University Hospital approval. Primary
human ESCs were purified as described previously [12].
In brief, the tissue specimens were washed in Dulbecco’s
modified Eagle’s medium (DMEM; Sigma-Aldrich, St.
Louis, MO) and minced with scissors into pieces less
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3 in size. The tissues were then gently agi-
tated in tubes for 2 h at 37°C in DMEM with 0.2% (wt/
vol) collagenase (Wako Pure Chemical Industries,
Osaka, Japan), 0.05% DNase I (Life Technologies, Inc.,
Gaithersburg, MD), 10% fetal bovine serum (FBS), and
1% antibiotic-antimycotic mixture (Life Technologies,
Grand Island, NY). After enzymatic digestion, cell
clumps were dispersed by pipetting. Most of the
digested human ESCs, presenting as single cells or small
aggregates, were filtered sequentially through a 70 μm
cell-strainer nylon filter (Falcon 2350; BD Biosciences,
Franklin Lakes, NJ) to remove gland cells, layered onto
Ficoll-Paque (GE Healthcare Life Sciences, Uppsala,
Sweden), and centrifuged at 500 × g for 15 min at 4°C
to remove erythrocytes. The isolated human ESCs were
collected from the Ficoll interface and resuspended in
DMEM with 10% FBS and 1% antibiotic-antimycotic
mixture.
Recombinant lentivirus preparations
Recombinant lentiviruses were prepared using the Vira-
Power Lentiviral Expression System (Life Technologies),
according to the manufacturer’s instructions. Full-length
cDNA of human telomerase reverse transcriptase isoform 1
(hTERT; GenBank accession number NM_003219) was
amplified by PCR from the total RNA of a colon cancer
cell line. The first-strand DNA was synthesized using
hTERT 3’-noncoding primer 5’-TGACAGGGCTGCT
GGTGTCTG and ReverTra Ace reverse transcriptase sys-
tem (Toyobo, Tokyo, Japan). The cDNA of the N-termi-
nus half of hTERT (1-2304) was amplified using forward
primer 5’-CACCATGCCGCGCGCTCCCCGCTGCCGA
and reverse primer 5’-GCCTTCTGGACCACGGCA-
T A C C G A ,a n dt h a to ft h eC-terminus half (1977-3399)
was amplified using forward primer 5’-CACCGG-
CACTGTTCAGCGTGCTCAACTACGAG and reverse
primer 5’-TCAGTCCAGGATGGTCTTGAAGTC. Each
cDNA was ligated to the pLenti6/V5-D TOPO vector.
Kozak sequences were introduced according to the
instruction manual. The fragment between SpeI( i nt h e
vector) and EcoRV sites from the N-terminus half was
then recloned in the same sites of the C-terminus half to
obtain the full-length hTERT plasmid (pLenti6-hTERT).
The DNA sequence of pLenti6-hTERT was completely
confirmed by DNA sequence analysis. pLenti6-hTERT
was then transfected to near-confluent 293FT cells (Life
Technologies) with helper plasmids (pLP1, pLP2, and
pLP/VSVG) to produce a lentivirus encoding hTERT
(LtV-hTERT). After 2 days of incubation at 37°C, the con-
ditioned mediums of the lentivirus-producing 293FT cells
were harvested and centrifuged at 3000 rpm for 15 min at
4°C. The supernatants were separated into aliquots and
stored at -80°C until use.
Immortalization of human ESCs
For immortalization, humanE S C sw e r ei n f e c t e dw i t h
LtV-hTERT in the presence of polybrene (6 mg/ml,
Sigma). The cells were grown in phenol red-free DMEM
supplemented with 10% dextran-coated charcoal-treated
FBS (DCC-FBS; Life Technologies) in the presence of 10
nM 17-b-estradiol (E2; E8875, Sigma) for 7-8 days until
uninfected cells died in the presence of 2 mg/ml blastici-
dine (Life Technologies). Then, the cells were trypsinized
and limiting-diluted in 96-well plates. Immortalized
clones were obtained in the presence of E2 under selec-
tion with blasticidine. The obtained clones were main-
tained in DMEM supplemented with 10% FBS, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 2 mg/ml blastici-
dine at 37°C under 5% CO2 in a humidified incubator.
The clones were tested for marker expression and
response to ovarian steroids and cAMP, as described
below. Finally, KC02-44D was selected as the most
responsive clone to the ovarian stimuli. We did not
obtain any clones responsive to these stimuli when pri-
mary human ESCs were cultured in the absence of E2.
In vitro decidualization and cytokine assay
KC02-44D cells were precultured in phenol red-free
DMEM supplemented with 10% DCC-FBS, 100 U/ml
penicillin, and 100 mg/ml streptomycin at 37°C over 4
days. They were then stimulated with or without 10 nM
E2, 1 μM6 a-methyl-17a-hydroxy-progesterone acetate
(MPA; M-1629, Sigma), and/or 0.125 mM dibutyryl
cAMP (D0627, Sigma) in combination with the indi-
cated concentrations of cytokines for different time peri-
ods according to the experimental procedures. Cell
images were acquired using a phase-contrast microscope
(Nikon). In the IL-1b experiment, KC02-44D cells were
treated with 1.0 ng/ml IL-1b (201-LB-005, R&D Sys-
tems, Minneapolis, MN) for 3-7 days, as described in
the figure legends.
Immunocytochemistry
KC02-44D cells were cultured in 96-well tissue culture
plates and characterized by immunofluorescence staining.
The cells were fixed with 4% paraformaldehyde (PFA;
Wako Pure Chemical Industries) solution for 30 min at
room temperature. After washing and permeabilization
with phosphate-buffered saline (PBS) containing 0.1%
Triton X-100, the cells were blocked with PBS-5% FBS at
4°C. The fixed cells were incubated in PBS-10% FBS con-
taining Cy3-labeled mouse anti-vimentin (C9080, 1:200;
Sigma), mouse anti-CD10 (clone SS2/36, 1:25; Dako,
Glostrup, Denmark), mouse anti-CD13 (clone WM-47,
1:50; Dako), or mouse anti-cytokeratin (clone MNF116,
1:50; Dako) antibody. After washing in PBS, the cells
were incubated with Alexa Fluor 488-labeled anti-mouse
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OR), washed again, and examined for each marker
expression under a fluorescence microscope (BZ-8000;
Keyence, Osaka, Japan).
Western blot analysis
Total proteins from KC02-44D cells were extracted with
Cell Lysis Buffer (Cell Signaling Technology, Beverly,
MA) containing 1 mM phenylmethanesulfonyl fluoride
(Sigma) on ice. The lysate was scraped and sonicated for
5 s by using an ultrasonic disruptor at output 1 (Tomy
Digital Biology, Tokyo, Japan). The sonicate was centri-
fuged at 15,000 rpm for 10 min at 4°C, and the protein
contents of the supernatant were measured using the
Bradford protein assay (Bio-Rad, Hercules, CA). After
the addition of lithium dodecyl sulfate sample buffer
(Life Technologies, Grand Island, NY) containing 2-mer-
captoethanol (Sigma), the samples were reduced at 70°C
for 10 min. Equal amounts of total proteins were then
electrophoresed on 4-12% NuPAGE Bis-Tris gels (Life
Technologies, Grand Island, NY) and transferred onto
polyvinylidene difluoride membranes (Immobilon-P;
Millipore, Bedford, MA), followed by blocking with 5%
nonfat dry milk in Tris-buffered saline containing 0.1%
Tween-20 (TBS-T). The membranes were then immu-
noblotted with the primary antibody against the
PR (clone PgR636, 1:800, mouse monoclonal; Dako),
IGFBP-1 (06-106, 1:1000, rabbit polyclonal; Upstate,
Millipore), or b-actin (1:3000, goat polyclonal; Santa
Cruz Biotechnology, Santa Cruz, CA) in TBS-T for 1 h
at room temperature. After washing thrice with TBS-T,
the membranes were further incubated with horseradish
peroxidase-conjugated anti-mouse, anti-rabbit (1:10,000;
GE Healthcare, Buckinghamshire, UK) or anti-goat
(1:5000; Jackson ImmunoResearch Laboratories, West
Grove, PA) secondary antibody in TBS-T for 1 h at
room temperature. After washing thrice with TBS-T
again, proteins were detected with ECL Plus reagent
(GE Healthcare) and visualized with LumiImager (Roche
Diagnostics, Penzberg, Germany).
Enzyme-linked immunosorbent assay (ELISA)
KC02-44D cells were plated at a density of 2 × 10
5 cells
per well in 6-well plates. Two days later, the medium
was changed and the cells were stimulated with E2,
MPA, and dibutyryl cAMP alone or in combination at
the indicated concentrations. The supernatants were
collected 6 or 7 days later, and the amounts of IGFBP-1,
PGE2, and IL-8 proteins were measured using ELISA
kits for IGFBP-1 (DY871, R&D Systems), prostaglandin
E2 (PGE2; KGE004, R&D Systems), and IL-8 (GE
Healthcare), respectively. Each treatment was performed
in triplicate wells.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from cultured KC02-44D cells
by using an RNeasy mini kit (Qiagen, Valencia, CA).
RT-PCR was carried out with 200 ng total cellular RNA
by using a One-Step RT-PCR kit (Qiagen). The primers
used for amplification were as follows: human estrogen
receptor-alpha (ERa), forward primer 5’-CAGGGGT-
GAAGTGGGGTCTGCTG-3’ and reverse primer 5’-
ATGCGGAACCGAGATGATGTAGC-3’; cyclooxygen-
ase-2 (COX-2), forward primer 5’-TGTCTTGACATC
CAGATCAC-3’ and reverse primer 5’-ACATCATGTTT
GAGCCCTGG-3’; b-actin, forward primer 5’-CCCA
GGCACCAGGGCGTGATC-3’ and reverse primer
5’-TCAAACATGATCTGGGTCAT-3’. Preliminary
experiments determined the optimum PCR cycle num-
ber within the linear range of amplification for each
gene being measured. After PCR amplification, the sam-
ples (15 μl aliquots) were electrophoresed in 2% agarose
gels, followed by photographic recording of ethidium
bromide-stained gels with FAS-III MINI (Toyobo). All
data from the RT-PCR analysis represent the results of
three independent experiments.
Cell-proliferation assay
Cell proliferation was determined using a Click-iT EdU
Alexa Fluor Imaging kit (Life Technologies, Grand Island,
NY), a modified 5-bromo-2’-deoxyuridine (BrdU) system
to detect DNA replication. In brief, KC02-44D cells (1.0-
1.5 × 10
3) were seeded onto 96-well culture plates with
phenol red-free DMEM containing 10% DCC-FBS and sti-
mulated with cytokines 48 h later. EdU (5-ethynyl-2’-deox-
yuridine) was added to a final concentration of 10 μMi n
the cell-culture medium and the cells were incubated for
24 h at 37°C. After fixation with 4% PFA and permeabili-
zation with 0.1% Triton X-100 in PBS, the cells were trea-
ted with the reaction cocktail containing Alexa Fluor 488
azide. The EdU intensity was measured using an ArrayS-
can VTi HCS reader (Thermo Scientific Cellomics, Pitts-
burg, PA). The colocalization bioapplication protocol was
used to acquire images with the appropriate filter sets in
two separate fluorescence channels: channel 1, Hoechst
33342 (nuclear reference and object identification); chan-
nel 2, EdU labeled with Alexa Fluor 488 azide (identifica-
tion of DNA-replicating S-phase cells in the cell cycle).
The cells were imaged with a 20 × objective and 0.63
numerical aperture with exposure times of 0.2 s (Hoechst
33342) and 0.1 s (Alexa Fluor 488 azide). The images were
collected as nine fields per well, and the values were
expressed as the mean average fluorescence intensity.
Statistical analysis
All quantitative experiments were conducted at least
three times each in triplicate wells. The results were
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shown in figures was the Mean ± SEM for triplicate
wells from one representative experiment.
Results
Characterization of KC02-44D cells
Immunocytochemical analysis
To assess specific antigen marker expression, KC02-44D
cells were fixed, permeabilized, and immunostained with
antibodies to endometrial stromal marker proteins. The
cells were positively stained with the stromal cell mar-
kers vimentin, CD10, or CD13, but not with the epithe-
lial cell marker cytokeratin (Figure 1).
Responses to ovarian steroids and cAMP
The decidualization capacity of KC02-44D cells against
ovarian steroids and cAMP was next examined. Decid-
ualized stromal cells are known to change into a round
morphology upon treatment with cAMP and a spindle-
shaped morphology upon treatment with MPA [9,10].
When KC02-44D cells precultured in the E2-free med-
ium were treated with E2, MPA, and dibutyryl cAMP
for 6 days, they transformed into a decidualized mor-
phology (Figure 2a).
KC02-44D cells were also tested for their response to
ovarian steroids and dibutyryl cAMP to induce IGFBP-
1, a decidualization marker [4]. MPA or dibutyryl cAMP
significantly but very weakly induced IGFBP-1 expres-
sion in the presence of E2. However, the protein expres-
sion was greatly induced by the combination of MPA,
dibutyryl cAMP, and E2 (Figure 2b), consistent with the
findings of a previous study on primary human ESCs
[13]. Prolactin, another decidualization marker, showed
similar responses to IGFBP-1 (See Additional file 1 Fig-
ure S1). KC02-44D cells maintain their response to
estradiol, progestin, and cAMP even at high passage
numbers (See Additional file 2 Figure S2).
We then assessed PR expression under stimulation by
ovarian steroids. Exposure of KC02-44D cells to E2
strongly upregulated the expression of both isoforms (A
a n dB )o fP R ,at a r g e tg e n eo fE R a in the endometrium
[14-18]. The E2-induced PR expression was significantly
downregulated after stimulation with MPA (Figure 2c),
consistent with reports on the endometrial decidualiza-
tion phase [7,13,19]. Therefore, KC02-44D cells were
considered to possess ESC characteristics, displaying
similar biochemical properties as well as cytoskeletal
marker and gene expression patterns to primary ESCs,
without any structural abnormalities.
Responses of KC02-44D cells to IL-1b
Regulation of inflammatory responses by IL-1b
Pro-inflammatory cytokine concentrations in peritoneal
fluid increase in women with endometriosis [20-22], and
IL-1b is suggested to play an important role in the
pathogenesis of endometriosis [5,6]. Therefore, we inves-
tigated the effect of IL-1b on the inflammatory
responses in KC02-44D cells. When the cells were trea-
ted with IL-1b, COX-2 gene expression was dramatically
enhanced (Figure 3a), and PGE2 and IL-8 secretion was
induced (Figure 3b and 3c). COX-2 and PGE2 induction
was canceled by the addition of MPA. In contrast, IL-8
induction by IL-1b could not be suppressed by MPA,
suggesting PR-independent regulation. The vehicle con-
trol yielded the same result as E2 (Figure 3b and 3c).
Figure 1 Expression of marker proteins in KC02-44D cells. PFA-fixed KC02-44D cells at passage number 10 were stained with antibodies
against vimentin (red) as well as CD10, CD13, and cytokeratin (green, with Hoechst blue for nuclear staining). No signal was detected in the
negative controls (no antibody; lower panels). Scale bars = 100 μm.
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Reportedly, stromal cells from endometriotic lesions and
the endometrium in women with endometriosis show
reduced decidualization capacity [23], and IL-1b inhibits
cAMP-mediated decidualization in primary human ESCs
[24-26]. Therefore, we tested whether IL-1b can reduce
the decidualization capacity of KC02-44D cells. IL-1b
drastically inhibited MPA- and dibutyryl cAMP-induced
IGFBP-1 expression (Figure 4a); moreover, the E2-
induced PR expression was significantly downregulated
after incubation with IL-1b (Figure 4b). The vehicle con-
trol yielded the same result as E2 for IGFBP-1expression
(Figure 4a and 4b).
Counteraction of ovarian steroid- and cAMP-induced
growth arrest by IL-1b
We used the EdU assay to assess whether IL-1b can
counteract MPA- and dibutyryl cAMP-induced growth
arrest of KC02-44D cells. In the absence of the ovarian
steroids and dibutyryl cAMP, IL-1b slightly enhanced
EdU incorporation to DNA, indicating the induction of
Figure 2 Induction of decidualization in KC02-44D cells. KC02-44D cells were treated with the indicated combinations of 10
-8 ME 2 ,1 0
-6 M
MPA, and 0.125 mM dibutyryl cAMP for 6 days to assess their decidualization capacity. (a) Phase-contrast microphotographs of living KC02-44D
cells at passage number 17 (scale bars = 100 μm). (b) Expression of decidualization marker IGFBP-1 in KC02-44D cells at passage number 15
(ELISA). The data represent the mean ± SEM of triplicate measurements. *P < 0.05 and ***P < 0.001 by Tukey’s test. (c) Expression of the ER
(RT-PCR analysis) and PR (Western blot analysis) in KC02-44D cells at passage numbers 15 and 16. b-Actin was used for normalization.
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tion mediated by MPA and/or dibutyryl cAMP, the cell
growth was significantly inhibited, observed as a reduc-
tion in the number of EdU-labeled S-phase cells (Figure
5, CTRL). In contrast, IL-1b treatment counteracted cell
growth arrest even in the presence of MPA and/or dibu-
tyryl cAMP (Figure 5, IL-1b), indicating the inhibition of
the decidualization capacity of KC02-44D cells.
Discussion
We established the KC02-44D cell line and found simi-
lar characteristics to primary human ESCs, showing the
synergistic induction of decidualization by progestin and
cAMP. Moreover, our cell line showed upregulation of
PR expression upon E2 stimulation, which is critical for
the progestin-dependent decidualization capacity of
ESCs. According to reports of immortalized cell lines, a
simian virus 40 large T antigen (SV40T)-immortalized
ESC line did not respond to E2 stimulation for PR
expression and prostaglandin production, possibly by
nonfunctional ERa [7], and another temperature-sensi-
tive SV40T-immortalized ESC line showed an adequate
decidualization phenotype only with cAMP stimulation,
even in the absence of progestin [11]. A recent hTERT-
immortalized cell line showed a robust response to pro-
gestin stimulation, but the synergistic effect of cAMP in
this cell line was not examined [9]. Another hTERT-
immortalized line showed progestin and cAMP synergy,
but in contrast to our clone, PR induction by E2 was
not noted in this cell line [10]. The reasons for these
discrepancies are not clear, but the differences in
human ESC sources or E2-supplemented culture condi-
tions for clone selection might affect the ability of each
cell line.
Human ESCs respond to IL-1b through induction of
COX-2 expression and PGE2 production. In primary
human ESCs, COX-2 mRNA is induced by IL-1b in a
p38 mitogen-activated protein kinase (p38MAPK)-
dependent manner and this induction is diminished by
progesterone or 8-bromo-cAMP through p38MAPK
Figure 3 Inflammatory responses of KC02-44D cells to IL-1b. KC02-44D cells were cultured with the indicated combinations of 10
-8 ME 2 ,
10
-6 M MPA, and 0.125 mM dibutyryl cAMP in the absence or presence of IL-1b (1.0 ng/ml) for 7 days to observe their inflammatory responses.
(a) Expression of COX-2 in KC02-44D cells at passage number 14 (RT-PCR analysis). b-Actin mRNA was used for normalization. (b) Expression of
PGE2 in KC02-44D cells at passage number 16 (ELISA). (c) Expression of IL-8 in KC02-44D cells at passage number 19 (ELISA). The data represent
the mean ± SEM of triplicate measurements. ***P < 0.001 by Tukey’s test. Letter a indicate differences between the control and IL-1b for each
stimulate: p < 0.001.
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regarding the inflammatory responses of KC02-44D
cells. Further, we observed induction of IL-8 production
upon IL-1b stimulation. However, progestin and/or
cAMP seemed to have no inhibitory effect on IL-8
expression. A previous study using endometriotic tissues
showed a similar observation, indicating the menstrual
cycle phase-independent expression of IL-8 and proges-
tin resistance of IL-1b-induced IL-8 production [28].
However, the mechanism of progestin resistance of IL-8
induction is currently unclear; a PR-dependent mechan-
ism might be responsible. At least distinct responses
were observed for COX-2 and IL-8 induction by IL-1b
in our cell line.
In the menstrual cycle, estrogen induces PR expres-
sion in the proliferative phase, and a high level of PR
expression is observed in the late proliferative phase;
this expression is downregulated according to the eleva-
tion in the serum progesterone level, followed by the
initiation of decidualization in the secretory phase
[29,30]. We have shown the regulation of PR expression
in this study. E2 strongly upregulated the expression of
the PR, and the E2-induced PR expression was signifi-
cantly downregulated after the stimulation with MPA
(Figure 2c). Compared with paired ectopic endometrial
specimens, a drastic loss of PR-B expression has been
observed in endometriotic tissues, resulting in progester-
o n er e s i s t a n c ei ne n d o m e t r i o s i s[ 3 1 ] .I L - 1 b-induced
inhibition of the decidualization capacity [24-26], activa-
tion of cell proliferation, and downregulation of PR-B
expression have been observed in primary ESCs [32].
We confirmed the effects of IL-1b on these responses in
KC02-44D cells.
Conclusions
We established an immortalized human ESC line, KC02-
44D, by introducing the hTERT gene into primary ESCs.
This clone showed characteristics such as decidualiza-
tion capacity and responses to IL-1b similar to primary
human ESCs. The KC02-44D cell line would be useful
to investigate the mechanisms of normal and pathologi-
cal human reproductive processes.
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